Judy E. Garber, MD, MPH

Judy E. Garber, MD, MPH
Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts

Judy E. Garber, MD, MPH | Class of 2013

An internationally recognized leader in clinical and translational research on breast cancer, Dr. Garber developed one of the first cancer risk and prevention clinics where programs are now being expanded to several types of cancer. She has led studies of epidemiology, cancer surveillance, cancer genetics service delivery, and chemoprevention in hereditary cancers.

Dr. Garber’s recent research has evaluated novel agents targeting DNA repair defects in treatment and prevention of triple-negative or basal-like breast cancer, the most common form of cancer in women with germline BRCA1 mutations. She has also studied pediatric cancers and sarcomas in Li-Fraumeni and hereditary gastrointestinal and stromal tumors.

Career Highlights

2019  ASCO American Cancer Society Award and Lecture
2018  Giants of Cancer Care, OncLive®, Cranbury, New Jersey
2017  AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research
2012  Elected Member, American Association of Physicians
2011-2012  President, AACR
2011  Professor of Medicine, Harvard Medical School
2010  Director, Center for Cancer Genetics and Prevention, Dana Farber Cancer Institute
2010  Axia Award, Hellenic Women’s Club
2009  Claire W. and Richard P. Morse Research Award, Dana Farber Cancer Institute
2008  Statesman Award, American Society for Clinical Oncology
2007  Tisch Family Outstanding Achievement Award, Dana Farber Cancer Institute
2007-2010  Board of Directors, AACR
2001  Elected to American Society for Clinical Investigation
1997-2000  Scholar in Clinical Research, The Dyson Foundation
1981  MD, MPH, Yale University School of Medicine